040_dataset_immunogenicity_repository.csv (1.82 MB)
Download file

H4:IC31 and BCG induced immune responses in a prevention of M. tuberculosis infection efficacy trial

Download (1.82 MB)
posted on 14.09.2020, 14:23 authored by Virginie RozotVirginie Rozot, Elisa Nemes, Munyaradzi MusvosviMunyaradzi Musvosvi, Asma Toefy, Thomas ScribaThomas Scriba
Immunogenicity responses from the C040-404 clinical trial were measured by whole blood intracellular cytokine staining at baseline and 70 days after vaccination with H4:IC31 (subunit vaccine containing Ag85B and TB10.4), Bacille Calmette-Guerin (BCG, a live attenuated vaccine) or placebo (n=~30 per group) using flow cytometry.



Sanofi Pasteur

Bill and Melinda Gates Foundation

Government of the Netherlands Directorate-General for International Development

the United Kingdom Department of International Development



Department of Pathology